Clinical Trial: Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06897917) titled 'Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain' on March 05.

Brief Summary: This study is a prospective, single-arm, multicenter, real-world study to evaluate effect of bowel function, analgesic effect, quality of life, and safety of Mimeixin(R) in Chinese patients with severe cancer pain.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Opioid-Induced Constipation Pain Cancer

Intervention: DRUG: Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets

1. Calculate the total opioid dosage administered to the patient in th...